115 related articles for article (PubMed ID: 38857045)
21. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
[TBL] [Abstract][Full Text] [Related]
22.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal assessment of hepatocellular carcinoma response to stereotactic body radiation using gadoxetate-enhanced MRI: A case series.
Sharma HK; Kyriakakos C; Jabbour TE; Ward S; Buckstein M; Taouli B; Lewis S
Eur J Radiol; 2023 Oct; 167():111077. PubMed ID: 37688918
[TBL] [Abstract][Full Text] [Related]
24. Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.
Juloori A; Katipally RR; Lemons JM; Singh AK; Iyer R; Robbins JR; George B; Hall WA; Pitroda SP; Arif F; Fung J; Pillai A; Liao CY; Sharma M; Liauw SL
Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):202-213. PubMed ID: 36108891
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
Yeung R; Beaton L; Rackley T; Weber B; Hamm J; Lee R; Camborde M; Pearson M; Duzenli C; Loewen SK; Liu M; Ma R; Schellenberg D
Clin Oncol (R Coll Radiol); 2019 Jun; 31(6):365-373. PubMed ID: 30792051
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F
Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic Body Radiation Therapy: A New Strategy for Loco-Regional Treatment for Hepatocellular Carcinoma While Awaiting Liver Transplantation.
Uemura T; Kirichenko A; Bunker M; Vincent M; Machado L; Thai N
World J Surg; 2019 Mar; 43(3):886-893. PubMed ID: 30361748
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
Kirichenko A; Gayou O; Parda D; Kudithipudi V; Tom K; Khan A; Abrams P; Szramowski M; Oliva J; Monga D; Raj M; Thai N
HPB (Oxford); 2016 Jan; 18(1):88-97. PubMed ID: 26776856
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of response after SBRT for liver tumors.
Tétreau R; Llacer C; Riou O; Deshayes E
Rep Pract Oncol Radiother; 2017; 22(2):170-175. PubMed ID: 28490989
[TBL] [Abstract][Full Text] [Related]
32. Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 Trial.
Buckstein M; Kim E; Özbek U; Tabrizian P; Gunasekaran G; Facciuto M; Rosenzweig K; Llovet JM; Schwartz M
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):221-230. PubMed ID: 35643250
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.
Beaton L; Dunne EM; Yeung R; Rackley T; Weber B; Mar C; Yong-Hing CJ; Yoshida EM; DeVries K; Lee R; Duzenli C; Loewen SK; Liu M; Schellenberg D; Ma R
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):423-432. PubMed ID: 32093876
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.
Yamashita H; Onishi H; Murakami N; Matsumoto Y; Matsuo Y; Nomiya T; Nakagawa K;
J Radiat Res; 2015 May; 56(3):561-7. PubMed ID: 25691453
[TBL] [Abstract][Full Text] [Related]
35. Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.
Kishan AU; Ma TM; Lamb JM; Casado M; Wilhalme H; Low DA; Sheng K; Sharma S; Nickols NG; Pham J; Yang Y; Gao Y; Neylon J; Basehart V; Cao M; Steinberg ML
JAMA Oncol; 2023 Mar; 9(3):365-373. PubMed ID: 36633877
[TBL] [Abstract][Full Text] [Related]
36. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.
Dholakia AS; Chaudhry M; Leal JP; Chang DT; Raman SP; Hacker-Prietz A; Su Z; Pai J; Oteiza KE; Griffith ME; Wahl RL; Tryggestad E; Pawlik T; Laheru DA; Wolfgang CL; Koong AC; Herman JM
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):539-46. PubMed ID: 24751410
[TBL] [Abstract][Full Text] [Related]
37. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
Mathew AS; Atenafu EG; Owen D; Maurino C; Brade A; Brierley J; Dinniwell R; Kim J; Cho C; Ringash J; Wong R; Cuneo K; Feng M; Lawrence TS; Dawson LA
Eur J Cancer; 2020 Jul; 134():41-51. PubMed ID: 32460180
[TBL] [Abstract][Full Text] [Related]
38. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of
Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
[TBL] [Abstract][Full Text] [Related]
40. A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
Sebastian NT; Miller ED; Yang X; Diaz DA; Tan Y; Dowell J; Spain J; Rikabi A; Elliott E; Knopp M; Williams TM
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1276-1283. PubMed ID: 32712254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]